Here are relevant reports on : pharmaceutical-contract-manufacturing-market
-
Filter Integrity Test Market by Test Type (Bubble Point, Diffusion, Water Flow), Mechanism (Manual, Automation), Filter Type (Air, Liquid), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academics) - Global Forecast to 2024
The Filter Integrity Test Market is projected to reach USD 79 million by 2024, growing at a CAGR of 5.0%. Factors such as increasing R&D spending, growth in the biopharmaceutical industry, and increasing purity requirements in the end-user market are driving the growth of the filter integrity test market. The major players in the filter integrity test market are Merck KGaA (Germany), Danaher Corporation/Pall Corporation (US), Sartorius (Germany), Donaldson Company (US), Parker Hannifin Corporation (US), Meissner Filtration Product (US), MDI Filtration Technologies (US), Thermo Fisher Scientific (US), Eaton Corporation (Ireland), and SH-Surway (China).
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) - Global Forecast to 2021
The global downstream processing market is projected to grow at a CAGR of 16.4%. In this report, the global downstream processing market is broadly segmented on the basis of technique, product, application, end user, and region.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031
The Veterinary Contract Manufacturing & Research market, valued at USD 5.92 billion in 2025, stood at USD 6.38 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of USD 9.24 billion by the end of the period. The market growth is driven by rising outsourcing of drug development and manufacturing, growing demand for advanced veterinary therapeutics such as biologics and vaccines, and the rising need for specialized research, testing, and GMP-compliant production capabilities.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application (Therapeutic, Research, Diagnostic), End User (Pharma, Biotech) - Global Forecast to 2029
The global oligonucleotide CDMO market, valued at US$2.33 billion in 2023, stood at US$2.51 billion in 2024 and is projected to advance at a resilient CAGR of 21.8% from 2024 to 2029, culminating in a forecasted valuation of US$6.73 billion by the end of the period. The increasing focus on precision/personalized medicine is also likely to contribute to market growth. Growing opportunities offered by emerging economies are accelerating innovation in the oligonucleotide CDMO field.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Healthcare Contract Management Software Market by Product & Service (Contract Lifecycle Management, Document Management), End User (Healthcare Providers, Hospitals, Physicians, Payers, Medical Device Manufacturers, Pharma) & Region - Global Forecasts to 2024
The healthcare contract management software market is projected to reach USD 1,763 million by 2024, growing at a CAGR of 18.5%. The prominent players in this market are Determine Inc. (US), CobbleStone Software (US), Concord (US), Contract Logix LLC (US), Icertis (US), Apttus Corporation (US), Coupa Software Inc. (US), Optum Inc. (US), nThrive Inc. (US), Experian Plc. (Ireland), and ScienceSoft (US).
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Manufacturing Execution System (MES) Market By Offering (Software, Services), Deployment (On-premises, Cloud, Hybrid), Application (Production Management, Quality Management, Performance Analytics, Predictive Maintenance) - Forecast to 2030
The Pharmaceutical Manufacturing Execution System market is expected to grow from USD 2.37 billion in 2025 to USD 4.62 billion by 2030, at a compound annual growth rate (CAGR) of 14.3 during the forecast period. The Key Players Siemens (Germany, Dassault Systèmes (France), SAP SE (Germany), ABB (Switzerland), Rockwell Automation (US), Honeywell International Inc. (US), Emerson Electric Co. (US), Yokogawa Electric (Japan), Schneider Electric (France).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Industrial Cooling System Market by End User (Power Generation, Industrial Manufacturing, Petrochemical Processing, Food Processing & Storage, Petroleum & Natural Gas Refining, Pharmaceutical, Data Center), Type & by Region - Global Forecasts to 2021
The global industrial cooling system market is projected to reach USD 17.24 Billion by 2021, at a CAGR of 5.0% between 2016 and 2021. This growth is mainly attributed to impressive development of power generation manufacturing industry in Asia-Pacific, increasing nuclear power generation capacities, and rising demand of cooling systems in thermal power generation industry.
- Published: July 2016
- Price: $ 4950
- TOC Available:
-
Sequence of Events Recorder Market by Mount type (Rack mounted, Rail mounted), End user (Data Center, Power Generation, Manufacturing, Others (Hospitals, Laboratories, Petrochemicals, and Pharmaceutical industries)), Region- Global Forecast to 2026
The sequence of events recorder market is expected to grow from USD 25 million in 2021 to USD 31 million by 2026, at a compound annual growth rate (CAGR) of 4.7% during the forecast period. Some of the key players are AMETEK(US), Qualitrol Corp.(US), Emerson(US), Yokogawa Electric Corporation(Japan).The leading players are adopting various strategies to increase their share in the sequence of events recorder market.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Quality Management Software (QMS) Market by Process (Clinical Trial, Regulatory, Manufacturing, Commercialization), Application (eSOP, CAPA, Compliance), Size (Large, Small), End User (pharma, biotech, CRO), Region - Global Forecast to 2030
The global pharmaceutical quality management software market is projected to reach USD 2.98 billion by 2030 from USD 1.59 billion in 2025, at a high CAGR of 13.3% during the forecast period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Continuous Manufacturing Market By Product (Integrated system, Semi-continuous (Granulator, Coater, Blender), Control), Application (API, End Product (Solid Dosage)), End User (R&D Department (CRO), Pharmaceutical Companies, CMO)- Global Forecast to 2022
The global continuous manufacturing market is projected to grow at a CAGR of 13.3%. Major players in this market include GEA Group AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bosch Packaging Technology (Germany), Coperion GmbH (Germany), and Glatt GmbH (Germany). Other players include KORSCH AG (Germany), Munson Machinery Company, Inc. (U.S.), L.B. Bohle Maschinen + Verfahren Gmbh (Germany), Gebrüder Lödige Maschinenbau GmbH (Germany), Baker Perkins Ltd. (U.K.), Scott Equipment Company (U.S.), and Sturtevant, Inc. (U.S.).
- Published: April 2017
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
